Analysts advised investors to subscribe to Concord Biotech IPO given its complex product portfolio, presence in niche space, strong client relationship and high entry barriers. The company is one of the leading global manufacturers of select fermentation-based APIs (F-APIs) across immunosuppressants and oncology with a market share of over 20% by volume in 2022.
Big movers on D-Street: What should investors do with Wipro, Infosys and LTIMindtree?
Benchmark Sensex fell for the third day, dropping nearly 495 points amid foreign fund outflows. Key stocks in focus included Wipro, Infosys, and LTIMindtree. Technical